Angion Biomedica Corporation

Osi Pharmaceuticals, Inc.

James G Tarrant

Bijoy Panicker

Rama K Mishra

Dong Sung Lim

Lambertus J W M Oehlen

Dawoon Jung

Xiaokang Zhu

Andrew Philip Crew

Jing Wang

Hanqing Dong

An-Hu Li

Mark Joseph Mulvihill

Xin Chen

Dan Maarten Berger

Arno G Steinig

Kam W Siu

Qinghua Weng

Andrew Kleinberg

Keith Hornberger

Ramesh C Gupta

Lifu Ma

Rajaram Sangem

Lambertus Jwm Oehlen

The present invention provides compounds having the general structural formula (I) and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving fibrosis and proliferation, and where anti-fibrotic or anti-proliferative activity is beneficial.

Cytochrome P450 inhibitors and uses thereof

The present invention provides compounds having the general structural formula (I) and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving fibrosis and proliferation, and where anti-fibrotic or anti-proliferative activity is beneficial. 

Compounds of Formula 1, as shown below and defined herein: 

7-aminofuropyridine derivatives

Growing community of inventors

Lindenhurst, NY, United States of America

James G Tarrant